Study of Low White Blood Cell Counts and Blood Types in Newborns
Part of Blood & lymphatic clinical trials.
This trial looks at how common a harmless condition called ethnic neutropenia (low white blood cells) and a specific blood type (Duffy null) are in newborns at Kaplan Medical Center. It helps doctors understand normal blood cell differences across ethnic groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby born at Kaplan Medical Center between September 1, 2024 and December 31, 2025.
- Parent gives permission for the study.
- Umbilical cord blood sample is available for testing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a way to track your blood counts at home using a finger-stick device and a smartphone app. It may help people with severe chronic neutropenia, a condition with very low white blood cells, manage their care more easily.
This trial is studying a condition called necrotizing enterocolitis in very small or premature babies. It looks for ways to better understand or treat this serious gut problem.
This study looks at how very low platelet levels (and platelet transfusions, if needed) affect bleeding and inflammation in newborns. It may help doctors better understand which newborns are at higher risk and how to manage low platelets.
This trial tests whether using specially prepared blood from umbilical cords (enriched with fetal hemoglobin) works better for premature babies who need blood transfusions. The goal is to see if this approach reduces complications and the number of transfusions needed during hospitalization.
This trial tests whether red blood cells made from donated cord blood are safe and effective for transfusions in extremely premature infants. It aims to see if this alternative blood source can help babies born before 28 weeks or weighing less than 1000 grams.
This trial tests if a single dose of umbilical cord blood cells can help patients whose blood counts stay dangerously low after CAR-T or antibody therapy. It aims to reduce the need for transfusions and improve recovery.
Hear when a new Neutropenia (Low White Blood Cell Count) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.